TAMPA, Fla.--(BUSINESS WIRE)--April 11, 2006--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), through its specialty pharmaceuticals subsidiary, TEAMM Pharmaceuticals, Inc., has received initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback